Professor and pediatrician Stephen Freedman will oversee the 26-site project, set to include more than 1,000 kids and run six years beginning in September 2022.
Freedman says the study will be the first in 20 years to evaluate a treatment focused on stopping disease progression. Infected children in the study will be hospitalized before any complications occur, even if they appear relatively well, Freedman said Tuesday in a release.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: